Search Results 1801-1810 of 18754 for Relapse

  1. Clinical Trials - M6620 First in Human Study

    Relapse within 3 months of completion of prior adjuvant or neoadjuvant chemotherapy; Any prior chemotherapy in the metastatic setting with the exception of ...

  2. Neurology - Clinical trials - Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  3. Neurology - Clinical trials - Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  4. Chronic lymphocytic leukemia - Survival rates - Mayo Clinic

    Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017; doi:10.1182/blood-2017-02-765685. Elsevier Point of Care ...

  5. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

    ... Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study. Morgensztern D. Daniel; Besse B. Benjamin; Greillier L. Laurent ...

  6. Phase I/II Study Of The Combination Of Blinatumomab And Asciminib In Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia - Mayo Clinic

    ... relapsed/refractory Ph-positive ALL or with previously treated lymphoid blast phase CML 2. Performance status ≤2 (ECOG Scale) if age ≥18 years or Lansky ...

  7. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide - Mayo Clinic

    The purpose of this study is to look at the effectiveness of using a study drug called cyclophosphamide (PTCy) to prevent graft versus host disease (GVHD) in ...

  8. Neurology - Clinical trials - Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  9. Neurology - Clinical trials - Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  10. Neurology - Clinical trials - Mayo Clinic

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...